Navigation Links
Ves-matic 20

ProductsVes-matic 20
Company Diesse Inc.
Item Ves-matic 20
Features 
  • Mixing and reading are fully automated and incorporated in the same instrument.
  • Homogeneous and standardized mixing.
  • Photometric infrared reading to avoid interference caused by the presence of lipids or bilirubin in the samples.
  • The end point ESR reading is elettronically timed and the actual value of the sedimentation is given.
  • The tube has an inclination of 18
  • Results in only 25 minutes
  • Temperature correction
Description A complete range of automatic systems for performing erythrocyte sedimentation rate (ESR) tests using 1 mL of blood. With the introduction of the Ves-matic System DIESSE brings to the clinical diagnostic market a truly revolutionary testing system which addresses and resolves every technical limitation associated with the traditional ESR techique. By means of a fully automated analyzer and a especially designed blood collection tube, the Ves-matic system upgrades the quality of the ESR procedure to the standards of modern laboratory medicine and offers a unique combination of safety and walk-away
Info Diesse Inc.
Customer Service: (877) 343-7733
Web site: http://www.diesse-usa.com/index2.html

Related medicine products :

1. Ves-matic 30
2. Ves-matic 10
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
50L...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Medicine Products:
(Date:9/17/2014)... Vegas, NV (PRWEB) September 17, 2014 ... Dr. Dan Ritchie and Dr. Cody Sipe that is helping ... of life and longevity has caught the attention of Shane ... most people in their 50s, 60s, or even 70s what ... of life on a day-to-day basis, they would probably answer ...
(Date:9/17/2014)... these sound like the ideas of a science ... of an exciting new approach to imaging local ... metastatic prostate cancer, scientists at Virginia Commonwealth University ... and Johns Hopkins Medical Institutions have provided proof-of-principle ... revolutionize doctors, ability to see tumors that have ...
(Date:9/17/2014)... Tidewater Physical Therapy and ... for football players and their parents at its Newport ... open at 6:30 p.m. for athletes and parents to ... and physical therapists. The workshop will start at 7 ... News Tidewater Performance Center, which features sports performance and ...
(Date:9/17/2014)... University] As Congress adjourns this month for the ... step over on their way out the chamber door ... Medicare Provider Payment Modernization Act of 2014. In a ... Dr. Eli Adashi recounts what he and other advocates ... The perennial trouble with how Medicare pays doctors will ...
(Date:9/17/2014)... Toledo, Ohio (PRWEB) September 17, 2014 ... hearing for today, September 17, 2014, to consider: , ... Testosterone Replacement Therapy (TRT), and, 2. ... of TRT. , With the TRT litigation ongoing, an ... FDA on the dangers of testosterone replacement therapy. Among ...
Breaking Medicine News(10 mins):Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2
... to Meet HRPA,s Stringent Pricing ... and Transparency Requirements, INDIANAPOLIS, ... benefit management (PBM) subsidiary, has,received Transparency in Pharmaceutical Purchasing Solutions ... the certification will enable WellPoint NextRx to offer PBM services,to ...
... Stand for Safe ... Patient Care, OAKLAND, Calif., Oct. 10 ... begin a two-day,strike at 15 Northern California hospitals this morning in California,s,largest strike ... of the big Sutter health chain and include some of the,largest hospitals in ...
... YORK, Oct. 10 On Oct. 23rd, the fashion ... Sadove, Chairman,and CEO of Saks Fifth Avenue, at "Fresh ... Youth and Families, which will take place at,The Pierre ... will,feature a performance by Judy Collins. The event, which ...
... Corporation, an,orthopedic implants company focused on silicon nitride ... on the in-vitro,testing and evaluation of its silicon ... HAP Paul Award from the International Society for,Technology ... which,was presented to Amedica at ISTA,s 20th Annual ...
... Oct. 10 Synova Healthcare Group,Inc. (OTC Bulletin ... in,the National Association of Nurse Practitioners in Women,s ... the New Millennium." The,NPWH is the leading association ... will take place October 10 - 13, in ...
... VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) ... Center for,Colorectal Health in Chicago. The new Clinic ... The additional clinic increases CRH,s overall,patient appointment capacity ... protocol. Commenting on the Chicago expansion, Edward ...
Cached Medicine News:Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 2Health News:Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association 3Health News:Two-Day Nurses Strike Begins Today 2Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 2Health News:Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families 3Health News:Amedica's Silicon Nitride Ceramic Bearing Technology Receives Prestigious HAP Paul Award for Use in Total Hip Arthroplasty 2Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 2Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 3Health News:Synova Healthcare to Participate in 'Women's Health Care in the New Millennium Conference,' as Retail Distribution for the Fem-V(R) Test Kit Expands 4Health News:CRH Medical Corporation opens second clinic in Chicago 2
(Date:9/17/2014)... TAMPA, Fla. , Sept. 17, 2014   ... announced today that Business Insurance magazine has ... Insurance" distinction for the third year in a row. ... joint effort of Business Insurance  and the Best ... evaluation, is open to all publicly or privately-held insurance ...
(Date:9/17/2014)... ANGELES and LEIPZIG, Germany ... today announced that it has entered into an ... the development of antibody-based imaging agents to image ... "Our collaboration with Novotectid expands ImaginAb,s capability to precisely ... immune-oncology and autoimmune disease areas. The ability to ...
(Date:9/17/2014)... PALO ALTO, Calif. , Sept. 17, 2014 /PRNewswire/ ... of the Company,s Phase 2 clinical program of NP001 ... Lou Gehrig,s disease) are being highlighted today ... of the ALS Research Group , being held in ... According to a  post hoc  analysis, administration of a ...
Breaking Medicine Technology:myMatrixx Honored with "Best Places to Work in Insurance" Award 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3